“…Concerning specificity, on the other hand, both methods have often achieved 100% (4, 34) and PLC not infrequently was superior (14,25,39,48). Currently however, yet promising, the detection molecular methods are not applied for routine use everywhere: sometimes, in fact, they provided controversial results (such as false-positive cases with mRNAs released by lymphocytes and sane mesothelial cells and other false-positives results due to isolated tumor cells -that is clinically insignificant cells without metastatic potential-and not to micrometastases -the utter active metastatic cells-) and, most of all, they are time-consuming, labor-intensive and expensive (1, 32,24,40). With this respect, testing novel ultra-rapid molecular methods (such as OSNA, TCR and LAMP) (33,34,40,43,54) with innovative targets isolated not only from PLs but also from blood or tissue specimens of AGC patients (65,66) could surmount some temporal and costly limitations of the current genetic techniques.…”